FrancophonIA/ELRC3.0 huggingface dataset:
English: MERIAL Animal Health Limited Biological Laboratory, Ash Road, Pirbright, Woking, Surrey GU24 0NQ UNITED KINGDOM
Danish: MERIAL Animal Health Limited Biological Laboratory, Ash Road, Pirbright, Woking, Surrey GU24 0NQ Storbritannien
English: A transient increase in body temperature, normally not exceeding an average of 1.1 °C, may occur within 24 hours after vaccination.
Danish: Forbigående temperaturforhøjelse, der normalt ikke overstiger et gennemsnit på 1,1oC, kan forekomme inden for 24 timer efter vaccination.
English: Do not use this veterinary medicinal product after the expiry date which is stated on the carton and the label after EXP.
Danish: Dette lægemiddel må ikke anvendes efter den udløbsdato, der er angivet på æsken eller etiketten efter EXP.
English: ANNEX II A. MANUFACTURERS OF THE BIOLOGICAL ACTIVE SUBSTANCES AND MANUFACTURER RESPONSIBLE FOR BATCH RELEASE B. CONDITIONS OR RESTRICTIONS REGARDING SUPPLY AND USE C. STATEMENT OF THE MRLs D. OTHER CONDITIONS AND REQUIREMENTS OF THE MARKETING AUTHORISATION
Danish: BILAG II A. FREMSTILLER AF DET BIOLOGISK AKTIVE STOFFER OG FREMSTILLER ANSVARLIG FOR BATCHFRIGIVELSE B. BETINGELSER ELLER BEGRÆNSNINGER FOR UDLEVERING OG BRUG C. ANGIVELSE AF MRL-VÆRDIER D. ANDRE FORHOLD OG BETINGELSER FOR MARKEDSFØRINGSTILLADELSEN
English: Name and address of the manufacturers of the biological active substances
Danish: Navn og adresse på fremstillerne af det biologisk aktive stoffer
English: SPECIAL STORAGE CONDITIONS Store and transport refrigerated (2 °C - 8 °C).
Danish: SÆRLIGE OPBEVARINGSBETINGELSER Opbevares og transporteres nedkølet (2°C - 8°C).
English: The duration of immunity is 1 year after primary vaccination course.
Danish: Immunitetens varighed:1 år efter primær vaccinations program.
English: Aluminium hydroxide
Danish: Adjuvanser: Aluminiumhydroxid
English: Laboratory of Lyon Porte des Alpes Rue de l'Aviation, 69800 Saint-Priest FRANCE
Danish: Laboratory of Lyon Porte des Alpes Rue de l'Aviation, 69800 Saint-Priest Frankrig
English: Special precautions for use in animals: Vaccinate healthy animals only.
Danish: Særlige forsigtighedsregler vedrørende brug til dyr: Vacciner kun raske dyr.
English: The manufacture, import, possession, sale, supply and/or use of BTVPUR AlSap 2-4 may be prohibited in a Member State on the whole or part of its territory pursuant to national legislation.
Danish: Fremstilling, indførsel, besiddelse, salg, levering og/eller anvendelse af BTVPUR AlSap 2-4 er eller kan være forbudt i en medlemsstat på hele eller en del af dens område i henhold til nationale lovgivning.
English: Silicon antifoam Phosphate buffer Glycine buffer Aluminium hydroxide Saponin.
Danish: Silikone antifoam Fosfatbuffer Glycinbuffer Aluminiumhydroxid Saponin
English: In this category of animals the vaccine should be used only according to the benefit-risk assessment by the responsible veterinarian and/or National Competent Authorities on the current vaccination policies against bluetongue virus (BTV).
Danish: Anvend derfor kun vaccinen til denne kategori af dyr i henhold til en benefit/risk-vurdering foretaget af den ansvarlige dyrlæge og/eller de nationale myndigheder, der er ansvarlige for den foreliggende vaccinationspolitik for bluetongue virus (BTV).
English: Pharmacotherapeutic group: inactivated bluetongue virus vaccine for sheep.
Danish: Farmakoterapeutisk gruppe: Inaktiveret bluetonguevirus vaccine, til får.
English: **Haemolytic units For the full list of excipients, see section 6.1.
Danish: **hæmolytiske enheder Se afsnit 6.1 for en fuldstændig fortegnelse over hjælpestoffer.
English: Onset of immunity has been demonstrated 3 and 5 weeks after the primary vaccination course for serotype 4 and serotype 2, respectively.
Danish: Immunitet er påvist 3 og 5 uger efter basisvaccinationsprogrammet for henholdsvis serotype 4 og serotype 2.
English: Any person intending to manufacture, import, possess, sell, supply and use BTVPUR AlSap 2-4 must consult the relevant Member State's competent authority on the current vaccination policies prior to the manufacture, import, possession, sale, supply and/or use.
Danish: Enhver, som har til hensigt at fremstille, indføre, besidde, sælge, levere og/eller anvende BTVPUR Alsap 2-4 skal rådføre sig med den relevante medlemsstats kompetente myndighed vedrørende gældende vaccinationspolitik forinden fremstilling, indførsel, besiddelse, salg, levering og/eller anvendelse finder sted.
English: Vaccination may be followed by a small local swelling at the injection site (at most 24 cm2) for a short period (at most 14 days).
Danish: Vaccination kan forårsage en mindre lokal hævelse på injektionsstedet (max. 24 cm2) i en kort periode (max. 14 dage).
English: MINIMUM PARTICULARS TO APPEAR ON SMALL IMMEDIATE PACKAGING UNITS Bottle of 10 or 50 ml
Danish: MINDSTEKRAV TIL OPLYSNINGER PÅ SMÅ INDRE PAKNINGER Flaske à 10 eller 50 ml
English: *below the level of detection by the validated RT-PCR method at 3.68 log10 RNA copies/ml, indicating no infectious virus transmission.
Danish: * under detektionsgrænsen for den validerede RT-PCR metode på 3,68 log10 RNA-kopier/ml, der indikerer, at der ikke er nogen infektiøs virustransmission..
English: Shelf life after first opening the immediate packaging: use immediately.
Danish: Opbevaringstid efter første åbning af den indre emballage: Anvendes umiddelbart.
English: Pregnancy and lactation: Can be used during pregnancy and lactation.
Danish: Anvendelse under drægtighed, laktation: Kan anvendes under drægtighed og laktation.
English: *(below the level of detection by the validated RT-PCR method at 3.68 log10 RNA copies/ml, indicating no infectious virus transmission)
Danish: *(under detektionsgrænsen for den validerede RT-PCR- metode på 3,68 log10 RNA-kopier/ml, der indikerer, at der ikke er nogen infektiøs virustransmission).
English: MARKETING AUTHORISATION NUMBER(S) EU/2/10/108/005
Danish: MARKEDSFØRINGSTILLADELSENS NUMMER (NUMRE) EU/2/10/108/005
English: *Cell culture infectious dose 50% equivalent to titre prior to inactivation (log10).
Danish: 30 HU** *Cell culture infectious dose 50% svarende til titer før inaktivering (log10) **hæmolytiske enheder
English: Polypropylene bottle of 50 or 100 ml with butyl elastomer closure.
Danish: Polypropylenflaske à 50 eller 100 ml med butylelastomer-prop
English: It induces an active and specific immunity against bluetongue virus serotypes 2 and 4 in the vaccinated animals.
Danish: Den inducerer en aktiv og specifik immunitet over for bluetonguevirus serotype 2 og 4 i vaccinerede dyr.
English: Active immunisation of sheep to prevent viraemia* and to reduce clinical signs caused by bluetongue virus serotypes 2 and 4.
Danish: Aktiv immunisering af får for at forebygge viræmi* og nedsætte kliniske symptomer forårsaget af bluetonguevirus serotype 2 og 4.
English: 50 doses (50 ml)
Danish: 50 doser (50 ml)
English: STATEMENT OF ACTIVE AND OTHER SUBSTANCES Each dose of 1ml of vaccine contains:
Danish: ANGIVELSE AF AKTIVE STOFFER OG ANDRE STOFFER Hver dosis på 1 ml vaccine indeholder:
English: The vaccine contains inactivated bluetongue virus serotypes 2 and 4 with aluminium hydroxide and saponin adjuvants.
Danish: Vaccinen indeholder inaktiveret bluetonguevirus serotype 2 og 4 med aluminiumhydroxid og saponin som adjuvans.
English: PACKAGE LEAFLET FOR: BTVPUR AlSap 2-4 suspension for injection for sheep
Danish: INDLÆGSSEDDEL: BTVPUR AlSap 2-4 suspension til injektion til får
English: Sheep
Danish: Får.
English: NAME OF THE VETERINARY MEDICINAL PRODUCT BTVPUR AlSap 2-4 suspension for injection for sheep
Danish: VETERINÆRLÆGEMIDLETS NAVN BTVPUR AlSap 2-4 suspension til injektion til får.
English: MARKETING AUTHORISATION NUMBER(S) EU/2/10/108/001 (1 bottle of 100 ml) EU/2/10/108/002 (10 bottles of 100 ml)
Danish: MARKEDSFØRINGSTILLADELSENS NUMMER (NUMRE) EU/2/10/108/001 (1 flaske á 100 ml) EU/2/10/108/002 (10 flasker á 100 ml)
English: PACKAGE SIZE 10 doses (10 ml)
Danish: PAKNINGSSTØRRELSE 10 doser (10 ml)
English: No adverse reactions except those mentioned in section 4.6 were observed after the administration of a double-dose of the vaccine.
Danish: Efter en dobbeltdosis med vaccinen er der ikke observeret andre bivirkninger end dem, der er nævnt i sektion 4.6.
English: A. MANUFACTURERS OF THE BIOLOGICAL ACTIVE SUBSTANCES AND MANUFACTURER RESPONSIBLE FOR BATCH RELEASE
Danish: A. FREMSTILLER AF DET BIOLOGISK AKTIVE STOFFER OG FREMSTILLER
English: Bluetongue virus serotype 2 antigen .............................................................................. 6.8-9.5 CCID50*, Bluetongue virus serotype 4 antigen .............................................................................. 7.1-8.5 CCID50*, Aluminium hydroxide
Danish: Bluetongue virus serotype 2 antigen ............................................................................. 6,8 - 9,5 CCID50* Bluetongue virus serotype 4 antigen ............................................................................. 7,1 - 8,5 CCID50* Aluminiumhydroxid
English: EU/2/10/108/003 (1 bottle of 50 ml) EU/2/10/108/004 (10 bottles of 50 ml) EU/2/10/108/001 (1 bottle of 100 ml) EU/2/10/108/002 (10 bottles of 100 ml)
Danish: EU/2/10/108/003 (1 flaske á 50 ml) EU/2/10/108/004 (10 flasker á 50 ml) EU/2/10/108/001 (1 flaske á 100 ml) EU/2/10/108/002 (10 flasker á 100 ml)
English: 10 bottles of 50 doses (10 x 50 ml) 100 doses (100 ml) 10 bottles of 100 doses (10 x 100 ml)
Danish: 10 flasker à 50 doser (10 x 50 ml) 100 doser (100 ml) 10 flasker à 100 doser (10 x 100 ml)
English: PARTICULARS TO APPEAR ON THE OUTER PACKAGE Box of 1 bottle of 50 ml, or of 10 bottles of 50 ml, or of 1 bottle of 100 ml, or of 10 bottles of 100 ml
Danish: Æske med 1 flaske à 50 ml Eller med 10 flasker à 50 ml Eller med 1 flaske à 100 ml Eller med 10 flasker à 100 ml
English: Box of 1 bottle of 10 doses (1 x 10 ml) Box of 1 bottle of 50 doses (1 x 50 ml) Box of 10 bottles of 50 doses (10 x 50 ml) Box of 1 bottle of 100 doses (1 x 100 ml) Box of 10 bottles of 100 doses (10 x 100 ml)
Danish: Æske med 1 flaske à 50 doser (1 x 50 ml) Æske med 10 flasker à 50 doser (10 x 50 ml) Æske med 1 flaske à 100 doser (1 x 100 ml) Æske med 10 flasker à 100 doser (10 x 100 ml)
English: DOSAGE FOR EACH SPECIES, ROUTE(S) AND METHOD OF ADMINISTRATION Administer one dose of 1 ml subcutaneously according to the following vaccination scheme: Primary vaccination
Danish: Administrer en dosis på 1 ml subkutant i henhold til følgende vaccinationsprogram: Basisvaccination
English: Primary vaccination
Danish: Basisvaccination
English: No adverse reactions except those mentioned in section ‘Adverse Reactions' were observed after the administration of a double-dose of vaccine.
Danish: Overdosering (symptomer, nødforanstaltninger, modgift), om nødvendigt: Der er ikke observeret andre bivirkninger efter en dobbeltdosis med vaccinen end de, der er nævnt i afsnittet Bivirkninger.
English: If used in other domestic and wild ruminant species that are considered at risk of infection, its use in these species should be undertaken with care and it is advisable to test the vaccine on a small number of animals prior to mass vaccination.
Danish: Særlige advarsler for hver enkelt dyreart, som lægemidlet er beregnet til: Vær forsigtig ved anvendelse af vaccinen til andre husdyr eller vilde dyrearter tilhørende drøvtyggere, som skønnes at være i risikogruppe for infektion.
English: Type I glass bottle of 10 ml with butyl elastomer closure.
Danish: Type I glasflaske à 10 ml med butylelastomer-prop Æske med 1 flaske à 10 doser (1 x 10 ml)
English: Bluetongue virus serotype 2 antigen ............................................................................... 6.8-9.5 CCID50* Bluetongue virus serotype 4 antigen ............................................................................... 7.1-8.5 CCID50* * Cell culture infectious dose 50% equivalent to titre prior to inactivation (log10) Adjuvants:
Danish: Bluetongue virus serotype 2 antigen ............................................................................. 6,8 - 9,5 CCID50* Bluetongue virus serotype 4 antigen ............................................................................. 7,1 - 8,5 CCID50* * Celle kultur infektiøs dosis 50%, svarende til titer før inaktivering (log10)
English: Once broached, use immediately.
Danish: Skal anvendes umiddelbart efter anbrud.
English: BTV2 antigen ................................................................................................................ 6.8-9.5 CCID50*, BTV4 antigen ................................................................................................................ 7.1-8.5 CCID50*, Aluminium hydroxide, Saponin, qs 1 dose *.
Danish: BTV2 antigen ............................................................................................................... 6,8 - 9,5 CCID50* BTV4 antigen ............................................................................................................... 7,1 - 8,5 CCID50* Aluminiumhydroxid, Saponin qs 1 dosis * * se indlægssedlen
English: BTV 2 antigen ................................................................................................................... 6.8-9.5 CCID50, BTV 4 antigen .................................................................................................................... 7.1-8.5 CCID50
Danish: BTV2 antigen .............................................................................................................. 6,8 - 9,5 CCID50*.
English: The name of the medicine was changed to Icandra on 6 February 2009.
Danish: Lægemidlets navn blev ændret til Icandra den 6. februar 2009.
English: The European Commission granted a marketing authorisation valid throughout the European Union for Vildagliptin/Metformin Hydrochloride on 1 December 2008.
Danish: Europa-Kommissionen udstedte en markedsføringstilladelse med gyldighed i hele Den Europæiske Union for vildagliptin/metforminhydrochlorid den 1. december 2008.
English: The full EPAR for Icandra can be found on the Agency's website ema.europa.eu/Find medicine/Human medicines/European Public Assessment Reports.
Danish: Den fuldstændige EPAR for Icandra findes på agenturets websted under ema.europa.eu/Find medicine/Human medicines/European Public Assessment Reports.
English: This is a summary of the European public assessment report (EPAR) for Icandra.
Danish: Dette dokument er et sammendrag af den europæiske offentlige vurderingsrapport (EPAR) for Icandra.
English: The recommended dose of Icandra is one tablet twice a day, with one tablet taken in the morning and one in the evening.
Danish: Den anbefalede dosis Icandra er en tablet to gange dagligt, hvor den ene tablet tages om morgenen og den anden om aftenen.
English: Other information about Icandra
Danish: Andre oplysninger om Icandra
English: Vildagliptin / metformin hydrochloride
Danish: Icandra vildagliptin/metforminhydrochlorid
English: For more information about treatment with Icandra, read the package leaflet (also part of the EPAR) or contact your doctor or pharmacist.
Danish: Hvis du ønsker yderligere oplysninger om behandling med Icandra, kan du læse indlægssedlen (også en del af denne EPAR) eller kontakte din læge eller dit apotek.
English: Icandra contains two active substances, which each have a different mode of action.
Danish: Icandra indeholder to aktive stoffer, som hver især virker forskelligt.
English: The applicant also presented the results of two studies showing that the active substances in the two strengths of Icandra were absorbed in the body in the same way as when they were taken as separate tablets.
Danish: Ansøgeren fremlagde også resultaterne af to undersøgelser, der viser, at de aktive stoffer i de to styrker af Icandra blev optaget i kroppen på samme måde, som når de blev taget hver for sig i to tabletter.
English: Icandra is used to treat adults with type 2 diabetes.
Danish: Icandra anvendes til behandling af voksne med type 2 diabetes.
English: The company that makes Eucreas has agreed that its scientific data can be used for Icandra.
Danish: Firmaet, som fremstiller Eucreas, har givet tilladelse til, at dets videnskabelige oplysninger må anvendes for Icandra.
English: It explains how the Committee for Medicinal Products for Human Use (CHMP) assessed the medicine to reach its opinion in favour of granting a marketing authorisation and its recommendations on the conditions of use for Icandra.
Danish: Det forklarer, hvordan Udvalget for Lægemidler til Mennesker (CHMP) vurderede lægemidlet og nåede frem til sin udtalelse til fordel for udstedelse af en markedsføringstilladelse og til sine anbefalinger om anvendelsesbetingelserne for Icandra.
English: Elderly patients taking Icandra should have their kidney function monitored regularly.
Danish: Ældre patienter, som behandles med Icandra, skal have deres nyrefunktion kontrolleret regelmæssigt.
English: Therefore, the Committee decided that the benefits of Icandra are greater than its risks and recommended that it be given marketing authorisation.
Danish: Udvalget var derfor af den opfattelse, at fordelene ved Icandra opvejer risiciene, og anbefalede udstedelse af markedsføringstilladelse.
English: The choice of tablet strength to start with depends on the patient's current treatment and the expected effects of Icandra, but it is recommended to provide a dose of metformin similar to the dose already being taken.
Danish: Valget af tabletstyrke i begyndelsen afhænger af patientens nuværende behandling og de forventede virkninger af Icandra, men det anbefales, at den dosis metformin, der gives, svarer til den dosis, der allerede tages.
English: Taking Icandra with or just after food may reduce any stomach problems caused by metformin.
Danish: Hvis Icandra tages sammen med mad eller lige efter et måltid, kan dette reducere eventuelle maveproblemer forårsaget af metformin.
English: Patients already taking vildagliptin and metformin should switch to Icandra containing the same amounts of each active substance.
Danish: Patienter, som allerede tager vildagliptin og metformin, bør skifte til Icandra, der indeholder de samme mængder af hvert af de aktive stoffer.
English: Icandra is a medicine that contains the active substances vildagliptin and metformin hydrochloride.
Danish: Icandra er et lægemiddel, der indeholder de to aktive stoffer vildagliptin og metforminhydrochlorid.
English: The most common side effects with Icandra (seen in more than 1 patient in 10) are nausea (feeling sick), vomiting, diarrhoea, abdominal (tummy) pain and loss of appetite.
Danish: De hyppigste bivirkninger ved Icandra (som ses hos flere end 1 ud af 10 patienter) er kvalme, opkastning, diarré, mavesmerter og appetitløshed.
English: Icandra should not be used in people who may be hypersensitive (allergic) to vildagliptin, metformin or any of the other ingredients.
Danish: Icandra bør ikke anvendes til personer, som kan være overfølsomme (allergiske) over for vildagliptin, metformin eller et af de øvrige indholdsstoffer.
English: The studies with Galvus as an add-on to metformin, metformin and a sulphonylurea, or metformin and insulin have been used to support the use of Icandra in the same indications.
Danish: Undersøgelserne af Galvus som tillægsbehandling til metformin, metformin og et sulfonylurinstof eller metformin og insulin blev anvendt til at underbygge brugen af Icandra til samme indikationer.
English: What is the risk associated with Icandra?
Danish: Hvilken risiko er der forbundet med Icandra?
English: In contrast, patients adding placebo had smaller changes in HbA1c levels, with a rise of 0.23 percentage points from a starting level of 8.3%.
Danish: I modsætning hertil havde patienter, som fik suppleret med placebo, mindre ændringer i HbA1cniveauerne med en stigning på 0,23 procent fra et udgangsniveau på 8,3 %.
English: For the full list of all side effects reported with Icandra, see the package leaflet.
Danish: Den fuldstændige liste over alle de indberettede bivirkninger ved Icandra fremgår af indlægssedlen.
English: Why has Icandra been approved?
Danish: Hvorfor blev Icandra godkendt?
English: • in combination with a sulphonylurea (another type of anti-diabetes medicine) together with diet and exercise, in patients whose diabetes is not satisfactorily controlled on metformin and a sulphonylurea.
Danish: • i kombination med et sulfonylurinstof (en anden type lægemiddel mod diabetes) sammen med diæt og motion til patienter, der ikke er tilstrækkeligt kontrolleret med metformin og et sulfonylurinstof,
English: Icandra should not be used in patients who have moderate or severe problems with their kidneys or who have problems with their liver.
Danish: Icandra bør ikke anvendes til patienter, der lider af moderat til svære nyre- eller leverproblemer.
English: Vildagliptin, which is a dipeptidyl peptidase 4 (DPP-4) inhibitor, works by blocking the breakdown of ‘incretin' hormones in the body.
Danish: Vildagliptin, som er en dipeptidyl peptidase-4 (DPP-4)-hæmmer, virker ved at blokere nedbrydningen af ‘inkretin'-hormoner i kroppen.Disse hormoner udskilles efter et måltid og stimulerer bugspytkirtlen til at producere insulin.
English: What is Icandra?
Danish: Hvad er Icandra?
English: What is Icandra used for?
Danish: Hvad anvendes Icandra til?
English: What benefit has Icandra shown during the studies?
Danish: Hvilken fordel viser undersøgelserne, at der er ved Icandra?
English: How has Icandra been studied?
Danish: Hvordan blev Icandra undersøgt?
English: How is Icandra used?
Danish: Hvordan anvendes Icandra?
English: How does Icandra work?
Danish: Hvordan virker Icandra?
English: MARKETING AUTHORISATION NUMBER(S) EU/1/18/1328/001
Danish: MARKEDSFØRINGSTILLADELSESNUMMER (-NUMRE) EU/1/18/1328/001
English: Pelmeg has not been tested in pregnant women.
Danish: Pelmeg er ikke blevet testet på gravide kvinder.
English: Do not use Pelmeg if
Danish: Brug ikke Pelmeg hvis
English: Do not shake Pelmeg vigorously as this may affect its activity.
Danish: Ryst ikke Pelmeg kraftigt, da dette kan påvirke virkningen.
English: If you forget to inject Pelmeg
Danish: Hvis De har glemt at indsprøjte Pelmeg
English: Pelmeg is for use in adults aged 18 and over.
Danish: Pelmeg er beregnet til voksne fra 18 år og opefter.
English: Pelmeg is a biosimilar medicinal product.
Danish: Pelmeg er et biosimilært lægemiddel.
English: INFORMATION IN BRAILLE Pelmeg
Danish: INFORMATION I BRAILLESKRIFT Pelmeg
English: However, the long-term effects of Pelmeg have not been established in AML; therefore, it should be used with caution in this patient population.
Danish: Den langsigtede virkning af Pelmeg er dog ikke blevet fastslået ved AML, og skal derfor anvendes med forsigtighed i denne patientpopulation.
English: Pelmeg left at room temperature for more than 96 hours should be discarded.
Danish: Pelmeg opbevaret ved stuetemperatur i mere end 96 timer skal kasseres.
English: • you are allergic to pegfilgrastim, filgrastim, E. coli derived proteins, or any of the other ingredients of this medicine.
Danish: • De er allergisk over for pegfilgrastim, filgrastim, proteiner stammende fra E. coli, eller et af de øvrige indholdsstoffer i dette lægemiddel.
English: Stop using Pelmeg and seek medical attention immediately if you notice any of the symptoms described in section 4.
Danish: Hold op med at bruge Pelmeg, og søg øjeblikkeligt lægehjælp, hvis De bemærker et eller flere af de symptomer, der er beskrevet i afsnit 4.
English: OTHER Mundipharma
Danish: ANDET Mundipharma
English: If you have forgotten a dose of Pelmeg, you should contact your doctor to discuss when you should inject the next dose.
Danish: Hvis De har glemt en dosis Pelmeg, kontakt da Deres læge for at aftale, hvornår De skal indsprøjte den næste dosis.
English: • Pelmeg is given as an injection into the tissue just under the skin (subcutaneous injection).
Danish: • Pelmeg gives som en injektion i vævet lige under huden (subkutan injektion).
English: Pelmeg may be used if it is accidentally frozen for two periods of less than 72 hours each.
Danish: Pelmeg kan bruges, hvis det utilsigtet fryses i 2 perioder, hver under 72 timer.